Literature DB >> 26013368

The Influence of Mining and Human Immunodeficiency Virus Infection Among Patients Admitted for Retreatment of Tuberculosis in Northern Tanzania.

Stellah G Mpagama1, Isaack A Lekule1, Alexander W Mbuya1, Riziki M Kisonga1, Scott K Heysell2.   

Abstract

In tuberculosis (TB)-prevalent settings, patients admitted for retreatment of TB may account for a high burden of poor treatment outcome. We performed a retrospective cohort study to characterize retreatment patients and outcomes at a TB referral hospital in northern Tanzania. From 2009 to 2013, 185 patients began a retreatment regimen, the majority for relapse after prior treatment completion. Men accounted for an unexpected majority (88%), 36 (20%) were human immunodeficiency virus (HIV) infected and for 45 (24%) mining was their primary occupation. A poor outcome (death, default, or persistent smear positivity after 7 months of treatment) was found in 37 (23%). HIV infection was the only significant predictor of poor outcome (adjusted odds ratio [aOR] = 2.50, 95% confidence interval [CI] = 1.07-5.83, P = 0.034). Interventions to minimize need for retreatment or improve retreatment success may be regionally specific. In our setting, community-based diagnosis and management among at-risk subpopulations such as miners and those HIV infected appear of highest yield. © The American Society of Tropical Medicine and Hygiene.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26013368      PMCID: PMC4530736          DOI: 10.4269/ajtmh.15-0189

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  18 in total

1.  Dust exposure during small-scale mining in Tanzania: a pilot study.

Authors:  Magne Bratveit; Bente E Moen; Yohana J S Mashalla; Hatua Maalim
Journal:  Ann Occup Hyg       Date:  2003-04

2.  Mining and risk of tuberculosis in sub-Saharan Africa.

Authors:  David Stuckler; Sanjay Basu; Martin McKee; Mark Lurie
Journal:  Am J Public Health       Date:  2010-06-01       Impact factor: 9.308

3.  Serum concentrations of rifampin, isoniazid, and intestinal absorption, permeability in patients with multidrug resistant tuberculosis.

Authors:  Elizabeth C Barroso; Valéria G F Pinheiro; Mônica C Façanha; Maria R D Carvalho; Maria E Moura; Creusa L Campelo; Charles A Peloquin; Richard L Guerrant; Aldo A M Lima
Journal:  Am J Trop Med Hyg       Date:  2009-08       Impact factor: 2.345

Review 4.  Silica, silicosis and tuberculosis.

Authors:  D Rees; J Murray
Journal:  Int J Tuberc Lung Dis       Date:  2007-05       Impact factor: 2.373

5.  Addressing institutional amplifiers in the dynamics and control of tuberculosis epidemics.

Authors:  Sanjay Basu; David Stuckler; Martin McKee
Journal:  Am J Trop Med Hyg       Date:  2011-01       Impact factor: 2.345

Review 6.  Why Do We Use 600 mg of Rifampicin in Tuberculosis Treatment?

Authors:  Jakko van Ingen; Rob E Aarnoutse; Peter R Donald; Andreas H Diacon; Rodney Dawson; Georgette Plemper van Balen; Stephen H Gillespie; Martin J Boeree
Journal:  Clin Infect Dis       Date:  2011-05       Impact factor: 9.079

7.  Factors associated with an increased case-fatality rate in HIV-infected and non-infected South African gold miners with pulmonary tuberculosis.

Authors:  G J Churchyard; I Kleinschmidt; E L Corbett; J Murray; J Smit; K M De Cock
Journal:  Int J Tuberc Lung Dis       Date:  2000-08       Impact factor: 2.373

8.  Aminoglycoside toxicity: daily versus thrice-weekly dosing for treatment of mycobacterial diseases.

Authors:  Charles A Peloquin; Shaun E Berning; Annette T Nitta; Patricia M Simone; Marian Goble; Gwen A Huitt; Michael D Iseman; James L Cook; Douglas Curran-Everett
Journal:  Clin Infect Dis       Date:  2004-05-05       Impact factor: 9.079

9.  Risk of pulmonary tuberculosis relative to silicosis and exposure to silica dust in South African gold miners.

Authors:  E Hnizdo; J Murray
Journal:  Occup Environ Med       Date:  1998-07       Impact factor: 4.402

10.  Blood cultures for the diagnosis of multidrug-resistant and extensively drug-resistant tuberculosis among HIV-infected patients from rural South Africa: a cross-sectional study.

Authors:  Scott K Heysell; Tania A Thomas; Neel R Gandhi; Anthony P Moll; François J Eksteen; Yacoob Coovadia; Lynette Roux; Palav Babaria; Umesh Lalloo; Gerald Friedland; Sarita Shah
Journal:  BMC Infect Dis       Date:  2010-12-06       Impact factor: 3.090

View more
  3 in total

1.  Identification of Risk Factors of Multidrug-Resistant Tuberculosis by using Classification Tree Method.

Authors:  Dixin Tan; Bin Wang; Xuhui Li; Xiaonan Cai; Dandan Zhang; Mengyu Li; Cong Tang; Yaqiong Yan; Songlin Yu; Qian Chu; Yihua Xu
Journal:  Am J Trop Med Hyg       Date:  2017-09-21       Impact factor: 2.345

2.  Risk factors for the treatment outcome of retreated pulmonary tuberculosis patients in China: an optimized prediction model.

Authors:  X-M Wang; S-H Yin; J Du; M-L Du; P-Y Wang; J Wu; C M Horbinski; M-J Wu; H-Q Zheng; X-Q Xu; W Shu; Y-J Zhang
Journal:  Epidemiol Infect       Date:  2017-04-11       Impact factor: 4.434

3.  High mortality during tuberculosis retreatment at a Ghanaian tertiary center: a retrospective cohort study.

Authors:  Tara Catherine Bouton; Audrey Forson; Samuel Kudzawu; Francisca Zigah; Helen Jenkins; Tsigereda Danso Bamfo; Jane Carter; Karen Jacobson; Awewura Kwara
Journal:  Pan Afr Med J       Date:  2019-06-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.